Amicus Therapeutics   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3
Founded: Cranbury NJ United States (2002)

Organization Overview

First Clinical Trial
2005
NCT00214500
First Marketed Drug
2018
migalastat (galafold)
First NDA Approval
2018
migalastat (galafold)
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

AmicusTherapeutics | Amicus Therapeutics | Amicus Therapeutics, Inc. | AMICUS THERAPS US | AMICUS THERAP US